Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B

Saved in:
Bibliographic Details
Published in:Infectious Diseases and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871475375914090498
collection WordPress RSS
FRELIP Feed Integration
container_title Infectious Diseases and Therapy
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:105457
institution FRELIP
journal_source_facet Infectious Diseases and Therapy
last_indexed 2026-07-23T03:39:59.775Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_alt Impacto del cambio de tenofovir disoproxil fumarato a tenofovir alafenamida o entecavir en pacientes mayores con hepatitis B crónica
Impact du passage du ténofovir disoproxil fumarate au ténofovir alafénamide ou à l'entécavir chez les patients âgés atteints d'hépatite B chronique
Impacto da Troca de Tenofovir Disoproxil Fumarato para Tenofovir Alafenamida ou Entecavir em Pacientes Idosos com Hepatite B Crônica
title_auth Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_es_txt Impacto del cambio de tenofovir disoproxil fumarato a tenofovir alafenamida o entecavir en pacientes mayores con hepatitis B crónica
title_fr_txt Impact du passage du ténofovir disoproxil fumarate au ténofovir alafénamide ou à l'entécavir chez les patients âgés atteints d'hépatite B chronique
title_full Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_fullStr Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_full_unstemmed Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_pt_txt Impacto da Troca de Tenofovir Disoproxil Fumarato para Tenofovir Alafenamida ou Entecavir em Pacientes Idosos com Hepatite B Crônica
title_short Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B
title_sort impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide or entecavir in older patients with chronic hepatitis b
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1007/s40121-026-01412-6